Regulatory approval of a gene therapy treatment in Europe could spark broader patient access to the technology.
Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
Researchers are using genomics to breed a better Thanksgiving bird.
A startup called GenePeeks will identify recessive diseases that could show up in children of sperm-bank clients and donors.
The system automatically pulls up patient files and lets nurses use mobile devices to document work.
The organ-mimicking microdevice may one day reduce the need for animal testing.
An MIT-Novartis collaboration could be a boost for so-called “continuous flow” manufacturing.
Algorithms tell government workers where to seek out the telltale mosquito larvae that causes the disease.
A fast, cheap way to identify neuron-to-neuron connections could shed light on disorders including autism and schizophrenia.
Researchers have created mice that are 500 times more sensitive than usual to TNT. They could provide a cheap, fast way to find buried explosives.
The nuclei of brain stem cells in some Parkinson's patients become misshapen with age. The discovery opens up new ways to target the disease.